Cell Potency Assays

Cell Potency Assays is a biological assessment method that quantifies the functional capacity of cells to differentiate, proliferate, or exert therapeutic effects, thereby distinguishing it from general viability or identity tests by specifically measuring the magnitude of a defined biological response relevant to the intended mechanism of action in cell-based therapeutics.

70

Publications

3.8K

Citations

703

Authors

163

Institutions

Publications per year

2017–2026

29

Authors

703

  1. HH
    Hongbing Huang

    Amgen (United States), United States

    3 publications · 121 citations

    3

    h-index

  2. OI
    O. I. Epstein

    Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences, Russia

    2 publications · 90 citations

    2

    h-index

  3. KG
    K.S. Gajiwala

    Pfizer (United States), United States

    2 publications · 115 citations

    2

    h-index

  4. RS
    Randy Serafino

    Bristol-Myers Squibb (United States), United States

    2 publications · 53 citations

    2

    h-index

  5. PP
    Pramod P. Mehta

    Pfizer (United States), United States

    2 publications · 115 citations

    2

    h-index

1–5 of 703

Venues

  1. Journal of Medicinal Chemistry

    14 publications · 735 citations

    14

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    5 publications · 135 citations

    5

    h-index

  3. PLoS ONE

    3 publications · 228 citations

    3

    h-index

  4. Stem Cell Reports

    2 publications · 149 citations

    2

    h-index

  5. Cell Transplantation

    2 publications · 82 citations

    2

    h-index

1–5